MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Wearing-off fluctuations"

  • 2024 International Congress

    Personality of Parkinson’s disease patients may influence the development and evolution of non-motor fluctuations

    M. Boussac, F. Faggianelli, E. Harroch, A. Eusebio, M. Fabbri, F. Ory-Magne, E. Descamps, O. Rascol, C. Laurencin, AR. Marques, M. Anheim, B. Giordana, L. Hopes, C. Moreau, AS. Rolland, D. Devos, D. Maltete, S. Ansquer, E. Hainque, S. Drapier, JP. Brandel, T. Rouaud, D. Guehl, B. Jarraya, M. Tir, T. Witjas, JP. Azulay, C. Brefel-Courbon (Toulouse, France)

    Objective: to evaluate the impact of personality on non-motor fluctuations (NMFs) in Parkinson’s disease (PD) and on NMFs evolution after dopaminergic treatments or deep brain…
  • 2024 International Congress

    When Off Can Cost Life: Myocardial Infarction Due to Spontaneous Coronary Dissection as a Catastrophic Manifestation in Advanced Parkinson’s Disease.

    S. Poveda, T. Lopez, B. Pascual Sedano, A. Campolongo (Bogotá, Colombia)

    Objective: Describe a patient with PD who suffered an acute myocardial infarction during a severe OFF period. Background: Advanced PD is characterized by complications including…
  • 2024 International Congress

    Criteria Defining Chronic Pain Associated with Parkinson Disease

    S. Perez-Lloret, J. Hunger, J. Bally, G. Kägi, J. Möller, N. Hollenstein, R. Gonzenbach, F. Brugger, D. Ciampi-de-Andrade, V. Mylius (Buenos Aires, Argentina)

    Objective: To assess the factors defining the association of chronic pain (>3 months) with PD. Background: Non-motor symptoms can be often associated with Parkinson disease…
  • 2024 International Congress

    Uncovering Patient Perspectives on Parkinson’s Disease to Inform Individualized Care

    A. Di Rocco, M. Armstrong, J. Carter, C. Chadha, K. Olson, L. Simone, L. Jarzylo (New York, USA)

    Objective: To gather patient insights on the burden of Parkinson’s disease (PD), understand the level of patient involvement in treatment decision-making, and determine overall satisfaction…
  • 2024 International Congress

    AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease

    SB. Soumma, D. Peterson, H. Ghasemzadeh, S. Mehta (Tempe, USA)

    Objective: This study developed a novel patient-independent, cost-effective AI model for detecting Freezing of Gait (FoG), using a single wearable sensor and without the need…
  • 2024 International Congress

    A Comparative Bioavailability Study between a Marketed Capsule-based Levodopa Dry Powder Inhaler and a New Pre-filled Levodopa Dry Powder Inhaler

    T. van Laar, F. Grasmeijer, M. Hoppentocht (Groningen, Netherlands)

    Objective: The primary objective was to determine the comparative bioavailability between a marketed and a new levodopa dry powder inhaler (DPI) with an enhanced usability…
  • 2023 International Congress

    On-demand therapy (ODT) in Parkinson’s disease: a survey of advanced practice providers

    K. Papesh, A. Merriam, C. Zebendon (Phoenix, USA)

    Objective: A survey of neurology Advanced Practice Providers (APPs) provides insights into their perspectives on managing and treating patients with Parkinson’s disease (PD) in the…
  • 2023 International Congress

    Motor complications in Parkinson’s disease

    S. Gandhi, T. Zerenner, A. Nodehi, M. Lawton, K. Grosset, V. Marshall, F. Al-Hajraf, Y. Ben-Shlomo, M. Hu, D. Grosset (Glasgow, United Kingdom)

    Objective: To determine the presence, severity, functional impact and predisposing factors of motor complications. Background: Motor complications are well recognized in Parkinson’s disease (PD), but…
  • 2023 International Congress

    Characterizing advanced Parkinson’s disease: OBSERVE-PD observational study – results of the Belgian subgroup

    V. van Iseghem, N. de Klippel, PH. Bourgeois, P. Bourgeois, T. Warlop, S. Dethy, E. Parmentier, D. Uyttersprot, K. Onuk, G. Garraux (Kortrijk, Belgium)

    Objective: The primary objective of the study was to evaluate the proportion of Parkinson’s Disease (PD) patients in Movement Disorder Centers with Advanced Parkinson’s Disease…
  • 2023 International Congress

    Continuous estimation of Parkinson’s on-off states using wearable devices

    A. Arnold, T. Jansen, R. Gilron, N. Cottone, J. Sayaan, W. Chen (San Francisco, USA)

    Objective: Utilize passive, continuous data from mobile and wearable devices to estimate on-off states in Parkinson’s patients. Background: The Hauser motor diary is often used…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 24
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley